glp 1 agonist mechanism Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review Understanding GLP-1 receptor agonists and

Adapted from Vniant, M.M

Bednarz, K

Statistics For the in vitro potency experiments, EC 50 values were log-transformed to achieve a normal distribution, and an F-test confirmed that there were no differences in variance between the populations

With these points in mind, we undertook a broad assessment of published clinical data, curating the body weight loss (% from baseline), glycosylated hemoglobin levels (HbA1c), and nausea responses (% patients reporting) from the SUSTAIN 3, SUSTAIN 7, SCALE Diabetes, SURPASS 2, and STEP 2 trials (64, 66, 67) ( Figures 1AC )

It also decreases glucagon secretion in a glucose-dependent manner and delays gastric emptying